Xiaogang Cheng

1.3k citations
28 papers · 1.0k indexed · h-index 16
Topics
HIV/AIDS drug development and treatment (6 papers)T-cell and Retrovirus Studies (5 papers)Animal Disease Management and Epidemiology (5 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Xiaogang Cheng

28 papers receiving 1.0k citations

Peers

Xiaogang Cheng
Comparison fields: 5 of 92
  • Molecular Biology 639
  • Immunology 353
  • Organic Chemistry 216
  • Oncology 104
  • Virology 87
Replace Kaori Asamitsu with:
Kaori Asamitsu Japan
Joshua L. Andersen United States
Rachel B. Kent United States
Malini Bajpai India
Tamara Tanos Argentina
Francesca Demarchi Italy
Donald M. Wallace United States
Dominik Filipp Czechia
Yea‐Lih Lin France
Yun Bai China
Xiaogang Cheng relative to Kaori Asamitsu Japan Kaori Asamitsu's profile →
Citations per field
00.5×3.5×
Kaori Asamitsu · 1×
Citations per year

Countries citing papers authored by Xiaogang Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiaogang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Cheng more than expected).

Fields of papers citing papers by Xiaogang Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaogang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Cheng. The network helps show where Xiaogang Cheng may publish in the future.

Co-authorship network of co-authors of Xiaogang Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Cheng. A scholar is included among the top collaborators of Xiaogang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Cheng. Xiaogang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 1
4 4
5 12
6 18
7 11
8 44
9 9
10 39
11 23
12 31
13 4
14 26
15 26
16 135
17 159
18 46
19 14
20 115

About Xiaogang Cheng

Xiaogang Cheng is a scholar working on Virology, Immunology and Agronomy and Crop Science, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), T-cell and Retrovirus Studies (5 papers) and Animal Disease Management and Epidemiology (5 papers). The work is most often cited by research in Virology (87 citations), Immunology (353 citations) and Sensory Systems (65 citations). Xiaogang Cheng has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Gerald W. Hart, Robert N. Cole, Lee Ratner, Joseph Zaia, Yi Pang, Pamela A. Lucchesi, Dacia L. Hunton, Louis J. Dell’Italia, Richard B. Marchase and Michael Belshan. Their work appears in journals such as Journal of Biological Chemistry, Blood and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026